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ABSTRACT 
BACKGROUND: Poor adherence to treatment is common in hemodialysis patients. 
However, effective interventions for this population are lacking. Small study trials of 
behavioral interventions have yielded improvements, but clinical effectiveness and 
long-term effects are unclear.  
STUDY DESIGN: Multi-center parallel (1:1) design, blinded randomized controlled 
trial. 
SETTING & PARTICIPANTS: Patients undergoing maintenance hemodialysis 
enrolled in 14 dialysis centers. 
INTERVENTION: Eligible patients were randomized to either usual care (control) 
(N= 101) or HED-SMART (intervention) (n=134). HED SMART developed using 
the principles of problem solving and social learning theory, was delivered by 
healthcare professionals over 4 group sessions. 
OUTCOMES AND MEASUREMENTS: Serum potassium and phosphate, 
interdialytic weight gains (IDWG), self-reported adherence and self-management 
skills at 2 weeks, 6- and 9-months post-intervention. 
RESULTS: A total of 235 participants were enrolled (response rate 49.6%). The 
study was completed by 74.8%. HEDSMART IDWG were significantly lowered 
across all four assessments relative to baseline in HED-SMART (p<.001) in contrast 
IDWGs in controls showed no change except at 3 months when it worsened 
significantly. Improvements in mineral markers were noted in HED-SMART at time 
3 (p<.001) and time 4 for potassium levels (p<.001). Phosphate levels improved in 
HED-SMART only at time 3 (p=.03), but these effects were not maintained at 9 
months post intervention (time 4). Significant differences between groups were found 
in secondary outcomes across all time points: self-reported adherence, self-
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management skills and self- efficacy.  
LIMITATIONS: Low proportion of patients with diabetes 
CONCLUSIONS: HED-SMART provides an effective and practical model for 
improving health in HD patients. The observed improvements in clinical and self-
report adherence, if supported and maintained at the longer follow-up, could 
significantly reduce ESRD-related complications in the longer term. Given the 
feasibility of this kind of program, it has strong potential for supplementing usual 
care. 
 
Trial Registration: ISRTN31434033 
 
Keywords: self- management; intervention; adherence; hemodialysis 
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INTRODUCTION 
In End Stage Renal Disease (ESRD), besides dialytic procedures, patient self-
management, or the ability and willingness of patients to change and subsequently 
maintain appropriate behaviors regarding diet, fluid intake and medicines is critical to 
maximizing good clinical outcomes. Adherence to this complex regimen is poor1 
contributing to morbidity, avoidable hospitalization, disability and death.2 Self-
management education facilitates the acquisition of knowledge and skills to improve 
disease management and has been found to improve health outcomes across a range 
of chronic diseases.3,4 Rigorously conducted randomized controlled trials (RCT) of 
self-management interventions specifically designed for patients on hemodialysis are 
however, limited.5,6,7,8 These systematic reviews indicate that prior interventions 
utilizing a self-management approach have shown benefit in self-care knowledge, 
quality of life and behavior yet are constrained by small sample sizes, highly selected 
patients, lack of control group and/or randomization and fairly short follow-ups. 
Further concerns are the limited data on clinical measures, and the use of rather 
intensive, non-pragmatic interventions, which have been poorly described, all making 
replicability and applicability difficult to assess. It is therefore not known whether 
similar effects can be achieved with a brief program or maintained in the long term. 
Given this lack of good quality evidence, we conducted a randomized 
controlled trial (RCT) to assess the short- and long- term effects of a practical, low-
intensity self-management intervention for hemodialysis patients who are 
socioeconomically disadvantaged and from a diverse ethnic background. It was 
hypothesized that the HEmoDialysis Self-MAnagement Randomized Trial (HED-
SMART) intervention would improve clinical outcomes, self-reported adherence, 
self-efficacy and self-management skills, in comparison to usual care. 
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METHODS 
Study Design 
The study methodology has been detailed elsewhere.9 In brief, the study was a 
multicenter, parallel-group blinded randomized controlled trial, with adult patients on 
hemodialysis randomized to either the intervention arm (HED-SMART) arm or ‘usual 
care’ arm (Control). Ethics approval was received from the National University of 
Singapore Institutional Review Board and written informed consent was obtained 
from study participants. The trial was registered at Current Controlled Trials 
(ISRTN31434033). 
Setting and Participants 
Patients were recruited from 14 of the 24 dialysis centers run by the National 
Kidney Foundation (NKF) Singapore, a non-profit charitable organization, which 
serves socioeconomically disadvantaged and middle income patients with ESRD in 
Singapore. Patients are admitted to the NKF program following means testing and are 
typically assigned to a dialysis center nearest to their residence.  NKF dialysis centers 
are located within the community, island wide, and are run by nurses with a team of 
nephrologists working in rotation.  
The participating dialysis centers were selected based on variability in size, 
location and proximity to designated facilities/sites hosting the intervention. There 
were no significant socio-demographic or ethnic differences across the dialysis 
centers in lieu of Singapore’s urban planning policies that ensure equal representation 
of ethnic groups in all parts of the island.  
Data were collected between January 2009 and June 2012. Inclusion criteria 
included being on HD for a minimum of 6 months, attendance for hemodialysis at one 
of the 14 selected NKF dialysis centers and aged over 21 years. Exclusion criteria 
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included current significant psychiatric disorders, learning disability or dementia, 
current medical disorder limiting life expectancy (all as recorded on medical records 
and verified by nurse managers), hearing impairment, and inability to communicate in 
English, Mandarin or Malay that precluded research participation. 
Randomization and Blinding 
To minimize contamination, the unit of randomization was dialysis shift 
within each of the participating dialysis centers, using computerized randomization 
(1:1 allocation ratio). Dialysis shifts rather than dialysis centers were preferred to 
diminish the influence of differences in practices. Allocation of randomization was 
concealed from study participants until consent and baseline assessment was 
completed. Consenting patients indicated their preferred language for intervention at 
baseline to guide subsequent arrangements for those allocated to HED-SMART.  
Healthcare professionals delivering the intervention were notified of the allocation 
after baseline assessment and before the first session; however, research assessors and 
all other staff remained blind to allocation at all assessment points.  
Study Arms 
Intervention. The intervention was developed with the MRC Framework for 
the evaluation of interventions to improve health.10 Based on social-cognitive 
theory11, the HED-SMART intervention was designed to enhance patients’ 
confidence and capability for self-management (imparting skills and strategies to 
support behavior change) and to target previously identified needs in this 
population.12 
The program was specifically designed for delivery in a ‘real-world’ setting, 
keeping the time commitment for both participants and facilitators to levels that could 
be readily achieved in most settings. It was delivered in group-format over 3 core 
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sessions plus 1 booster session (total contact 8 hours). An additional telephone 
follow-up call was scheduled in the interim between the core curriculum and booster 
session. 
The sessions were interactive and targeted self-management behaviors related 
to fluid, diet, and medication through goal setting, barrier identification and problem 
solving. Learning was elicited rather than taught, with facilitators using a non-didactic 
approach. Participants were encouraged to share insight and experiences so as to yield 
a platform for identifying strengths, unknown resources and discovering new 
strategies for problem solving through peer support.13 The intervention was delivered 
in addition to usual care and participants also received the ‘Healthy Eating for People 
on dialysis’ educational booklet. 
The intervention was made available in English (n=6), Mandarin (n=5) or 
Malay (n=3), hence a total of n=14 groups were conducted. 
Two renal health care professionals (Medical Social Worker; Renal Nurse or 
Renal Dietician) worked in pairs to facilitate the groups. Intervention facilitators 
completed a 2-day training course and received the HED-SMART manual detailing 
content and procedures for each session. Three pilot groups were run prior to the main 
program to refine procedures and establish competence and fidelity for facilitators 
(n=6). Periodic review of sessions, monthly calls or briefings were conducted 
thereafter to address issues/provide feedback, and ensure maintenance of skills and 
consistency across sites. 
Usual care control. Patients randomized to the control condition received 
standard renal care, which included the ‘Healthy Eating for People on dialysis’ 
educational booklet.  
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Incentives 
All participants received S$10 at each evaluation completed (S$40 total). 
Intervention participants received an additional travel reimbursement of S$25 for each 
intervention session attended, to cover travel on non-dialysis days (S$100 total).  
Measures 
Measurements were taken at baseline [T1], 1 week post-intervention (after 
completion of core-curriculum) [T2], 3 months (following telephone call and booster 
session) [T3] and 9 months post-intervention [T4; no contact/maintenance phase].  
The primary outcomes were serum potassium, phosphate levels and 
interdialytic weight gains (IDWGs). IDWGs were calculated as follows: the mean of 
absolute pre- to post-dialysis body weight at the midweek dialysis sessions over the 
assessment period (up to 4 weeks prior to T0 baseline; ±4 weeks for T2-T4); and the 
ratio of mean absolute IDWG to patient’s mean dry weight at each midweek 
assessment (up to 4 weeks prior to T0 baseline; ±4 weeks for T2-T4) expressed as 
IDWG%. Values ≥4.0% were considered suboptimal.14,15 
Biochemical data were collected through regularly scheduled blood work 
(samples drawn pre-dialysis) and were analysed in both continuous [i.e. change in 
mean serum levels from baseline to follow-up assessments] and categorical forms [i.e. 
% participants meeting clinical targets across assessments]. The KDOQI target ranges 
were used as the reference category. 
Secondary outcomes included self-report adherence, self-efficacy and self-
management skills.  
Self-reported adherence was measured with the Renal Adherence Behaviour 
Questionnaire (RAAQ)16, which includes 5 subscales: adherence to fluid restrictions; 
potassium and phosphate, sodium intake; adherence in times of difficulty; and self-
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care. The self-care subscale was subsequently dropped due to a low reliability 
coefficient (α = .363). Higher scores in all subscales signify better adherence.  
The Medication Adherence Questionnaire was used to determine self-reported 
adherence to patients’ prescribed medication17 with higher scores signifying better 
medication adherence.  
Self-management skills were measured using the self-monitoring and insight, 
constructive attitudes and approaches, skill and technique acquisition, and health 
service navigation subscales of the Health Education Impact Questionnaire Version 2 
(HeiQ), a validated tool for evaluating self-management interventions.18  
Self-efficacy was measured using a validated six-item scale.19 Higher scores 
indicate better self-efficacy. Eight additional, similarly constructed renal-specific 
items were added to measure confidence regarding dialysis-specific recommendations 
related to fluid intake, diet and medication.9 The internal reliability coefficient for 
these new items was high (α=0.92), hence an aggregate score was computed. 
Sociodemographic data for age, gender, ethnicity, marital status, living 
arrangements, income and employment were assessed using a brief checklist. 
Statistical Analyses 
All analyses were performed in accordance with the CONSORT statement20 
using IBM SPSS Statistics 20.0 (Chicago, IL, USA). Chi-square tests and analyses of 
variance (as appropriate) were used to evaluate differences between study arms, and 
between dropouts and those who completed the study.  
Changes within groups over time were assessed by mixed model repeated 
measures analysis of variance with two factors; time (T1/T2/T3/T4) and group (HED-
SMART vs. usual care). When differences between trial arms at baseline were 
observed, these values were entered as covariates. Prior to analyses, the assumptions 
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regarding normality, homogeneity of variance and covariance, and sphericity were 
checked. Huynh–Feldt or Greehouser-Geisser corrections were applied when and as 
appropriate. All p values <.05 were considered statistically significant. Effect sizes 
were estimated using Cohen d.   
Primary analyses were based on intention-to-treat (ITT) population, (all 
randomly assigned participants, including those without post-baseline observations). 
Missing values were imputed using the last Observation Carried Forward (LOCF) 
method.21 As sensitivity analysis, per protocol (PP) approach was used in which 
participants with missing data were excluded.  
RESULTS 
Sample Characteristics 
A total of 956 dialysis patients receiving care at the participating dialysis 
centers were assessed for eligibility. Of these participants, 532 (55.6%) were deemed 
eligible. A total of 259 (48.7%) provided consent and 235 (44.2%) completed the 
baseline assessment and were subsequently randomized (based on dialysis shift) to 
HED-SMART intervention (n=101) or usual care (n=134) [see figure 1].  Patients' 
characteristics were similar between groups at baseline (Table 1). 
Insert Table 1. 
Retention and Completion Rates 
Overall retention through study completion was 82.1% (n=193). Complete case 
data (per protocol) for all clinical markers and questionnaires across all time points was 
80% (n=189). Attrition rates were significantly greater in the intervention (25.7%; 
n=26) than usual care (11.9%; n=16) (p=.01). This was largely due to not being able to 
form a preferred language group for n=6 participants randomized to intervention arm 
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(no commencement rather than discontinuation). There were no differential attrition 
rates between study arms when these subjects were excluded.  
Insert Figure 1. 
The only significant differences between study completers and those who 
withdrew or were lost to follow-up were in dialysis vintage (5.44±4.30 years vs. 
7.69±6.32 years; p=0.04), adherence at difficult times (18.63±3.29 vs. 20.17±3.35; 
p=.007), and mean IDWGs (2.46±.69 vs. 2.12±.57; p=0.006) respectively, signifying 
shorter dialysis vintage and lower adherence (self-reported and as indexed by 
IDWGs) at baseline for completers. Little MCAR test was non-significant indicating 
that the data were likely to be missing completely at random. Four participants died of 
cardiovascular causes during the course of the study (two from each study arm) and 
were excluded from the analyses. No other adverse events were reported. 
Attendance 
The majority of HED-SMART participants (n=69; 60.5%) attended all four 
sessions, 89 (87.2%) attended three sessions and 94 (92.2%) attended between one 
and two sessions. Six participants did not receive the allocated intervention, as we 
were unable to form preferred language groups. There were no differences in any of 
the baseline characteristics between these subgroups. 
Primary Outcomes 
HED-SMART participants demonstrated significant improvements on all 
clinical outcomes across the study period relative to baseline and usual care. 
Significant effects were consistently noted at T3 and some, but not all of these effects 
persisted at T4 (see Table 2).   
Insert Table 2. 
Repeated-measures ANOVAs revealed a significant time-by-group interaction 
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effect for mean IDWG (F=6.32, p=0.001) and percentile IDWGs (F=4.59, p=0.005). 
Post hoc comparisons indicated significant IDWG reductions from baseline (T1) to all 
follow-up assessments in HED-SMART: at 1 week (T2; pmIDWG<0.001; d=-0.59; 
p%IDWG<0.001; d=-0.53), 3 months (T3; pmIDWG=0.004; d=-0.42; p%IDWG=0.01; d=-
0.37) and 9 months post-intervention (T4) for mean (pmIDWG=.002; d=-0.46) and 
percentile IDWGs (p%IDWG=0.002; d=-0.46). Usual care controls had worsening only 
at T3 (p=0.02 d=0.29 for mean IDWGs) relative to baseline. Percentile IDWGs for 
controls remained unchanged (with an improvement between T3 and T4). 
The reductions in IDWGs were significant relative to usual care at both T2 
(pmIDWG=0.04; d= -0.28; p%IDWG=.02; d=-0.31) and at T3 (pmIDWG=0.02; d=-0.31; 
p%IDWG=0.02; d=-0.32) for mean IDWGs and percentile IDWs respectively. Although 
there were no longer significant differences between conditions in IDWGs at T4, the 
patterns differed between groups. Both mean and percentile IDWGs relapsed to 
baseline levels for usual care (p<.01) whilst for HED-SMART IDWGs remained 
significantly lower than baseline showing sustained effects at both T3 and T4. 
The study considered IDWG% of ≥4.0% weight to be indicative of poor fluid 
control. At baseline 42.4% of participants in the HED-SMART program and 46.6% of 
those in usual care had IDWG% of ≥4.0%. Post-intervention, 32.7% vs. 48.1%; 
30.6% vs. 53.4%, 30.6% vs.45.1% of HED-SMART compared to usual care had high 
IDWG%, at T2, T3 and T4 respectively. Group effects were significant at all follow 
up assessments (T2, p=0.02; T3 p=0.001; T4 p=0.03) (Table 2). 
 
Mineral markers showed a similar pattern of improvement (see Table 2). 
Repeated-measures ANOVAs showed a significant time-by-group interaction effect 
for phosphate levels (F=2.79; p=0.04) (See figure 2). Changes in HED-SMART were 
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significant from baseline (T1) to 3 months post-intervention (T3)(p=.03, d=-0.32), but 
not from baseline to T2 or to T4. Phosphate levels increased from T3 to T4 indicating 
loss of effect at 9 months (p=0.05, d=0.29).  
Levels of phosphate remained undifferentiated in the control group at T2 and 
T3, but significantly increased at T4 (p=0.03, d=0.27) relative to baseline. The 
differences between the groups were statistically significant at both T3 (p=0.01; d=-
0.33) and T4 (p=0.03; d=-0.30), indicating significantly lower phosphate levels for 
HED-SMART relative to usual care. Proportions of patients achieving clinical targets 
were significantly higher for HED-SMART relative to usual care only at T3 (p = 
0.01) (Table 2). 
Potassium levels too showed a differential course within trial arms (F = 13.51; 
p< 0.001). The HED-SMART showed significant reductions in potassium levels 
relative to baseline at both T3 (p<0.001; d=-0.68) and T4 ( p=0.03 d=-0.31), but not 
T2 (p=0.2). It is of note that improved levels were maintained at T4 despite some loss 
of effect from T3 to T4 (p=0.02; d =0.33).  The usual care group showed no change 
over time. Differences between groups were significant only at T3 (p<0.001, d=0.50). 
Classification based on clinical targets indicated significantly lower off target values 
for HED-SMART compared to usual care, only at T3 (p=0.02). 
 
PP analyses to explore the impact of missing data indicated that whilst coefficients 
differed, overall patterns of effects remained the same.   
 
Secondary Outcomes 
Levels of self-reported adherence, self-efficacy, and self-management skills 
changed differentially over time between study arms (Table 3). There were significant 
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time-by-group interaction effects for overall self-reported adherence (F=6.86, 
p<0.001), adherence to fluid restrictions (F=4.65, p=0.004), adherence to potassium 
and phosphate intake (F=5.06, p=0.002), adherence in times of difficulty (F=4.49, 
p=0.005), skills and technique acquisition (F=3.60, p=0.2), health services navigation 
(F=5.78, p=0.001), disease-related self-efficacy (F=2.66, p=0.5), and dialysis 
treatment-related self-efficacy (F=6.63, p<0.001). However, there were no significant 
interaction effects for adherence to sodium intake (F=2.36, p=0.07), adherence to 
medications (F=2.46, p=0.07), self-monitoring and insight (F=2.20, p=0.1), or 
constructive attitudes and approaches (F=0.07, p=0.9).  
The usual care control group showed little variation over time, with only some 
decline in T2 on overall self-reported adherence, adherence to potassium and 
phosphate intake, adherence in times of difficulty, and treatment-related self-efficacy. 
In contrast, improvements were noted consistently from baseline to all follow-up 
assessments for HED-SMART. The effects were greatest from baseline to T2, 
leveling off in T3 and T4. These changes remained statistically significant at T3, and 
most importantly at 9 months post-intervention (T4), relative to baseline. The only 
exceptions were adherence in times of difficulty, and disease and treatment self-
efficacy, where changes were only significant at T2, and not subsequent follow-ups. 
Group comparisons also indicated that secondary outcomes at all follow-ups were 
improved in HED-SMART relative to usual care (see Table 3).  
DISCUSSION 
The current study reports the results of a RCT to explore the effectiveness of a 
self-management intervention for patients with ESRD on hemodialysis in comparison 
to usual care. The HED-SMART program was found to reach a representative 
proportion of those contacted and considered to be eligible and had a good retention 
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rate.  
There was evidence of improvement on all clinical outcomes for HED-
SMART relative to baseline. These were consistently noted at 3 months post-
intervention, in line with previous work.7,22 Although there was no further 
improvement at the final follow-up, relapse was modest. IDWGs and potassium levels 
increased from T3 to T4, but still remained significantly lower than baseline 
indicating persisting effects. Phosphate levels relapsed back to baseline at T4, but 
were still significantly lower in HED-SMART than usual care.  
This loss/attenuation of effect after the completion of a structured self-
management program is related to the impending challenge of maintaining behavior 
change and has been reported elsewhere in the chronic illness literature.23,24 This has 
implications on how to structure and deliver programs so as to address difficulties 
around transitioning patients from organized, structured support back to usual care. 
The finding that improvements were most marked at 3 months, where contact was 
reduced, to a telephone call and booster session, seem to suggest that delivery of self-
management techniques may be possible with minimal contact in order to prevent 
relapse. These could be easily woven into the planned program and routine care to 
provide an ongoing line of support to reinforce the gains of the core intervention 
program. The use of personal digital devices and mobile technology may be particular 
useful. 
The primary trial outcomes were chosen as objective indicators of disease 
management with established associations with longer-term complications and 
mortality.25,26,27 They are however distal outcomes for an intervention that seeks to 
empower patients to be active managers and may also be influenced by factors other 
than behavior, such as prescribed medications, hyperparathyroidism, inflammation 
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and dialysis dose.28 Self-management skills, self-efficacy and self-reported adherence 
reflect more proximal effects that are a prerequisite for behavior change and hence 
better clinical outcomes. HED-SMART yielded benefits in the skills patients gained 
and their confidence at 3 months post-intervention and these effects were maintained 
at the 9 months follow-up assessment for skills acquisition. These indicated a greater 
understanding by the participants of their condition and treatment, and greater 
confidence in their ability to navigate health services, manage treatment and affect the 
course of their illness. Participants in HED-SMART also improved significantly more 
than the usual care on self-reported adherence to fluid and diet restrictions. Changes 
in behavior therefore followed a similar trajectory as that of clinical markers. 
Encouragingly the observed effect sizes reflect findings of a meta-analysis of a range 
of chronic illness self-management programs.29  
Despite the success of the project, there are study limitations that need to be 
considered. First and foremost, the trial recruited a convenience sample of eligible 
participants rather than a probability-based sample, which limits generalizability to 
other populations. Although the current sample represents fairly well the national HD 
population and other renal registries [49], the rate of diabetes was lower in this 
sample. Replication is therefore warranted. Moreover, self-selection bias cannot be 
ruled out. It is possible that volunteers were highly motivated to change their 
behavior, thereby influencing the study outcomes in a positive direction. Furthermore, 
since we used broad inclusion criteria and did not confine recruitment to those poorly 
controlled, ceiling effects could have been experienced by participants who either met 
clinical targets or were already close to achieving them. However, even with these 
potential ceiling effects, the intervention was shown to improve outcomes and 
significantly protect against the likelihood of subsequent non-adherence and poor 
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clinical markers. 
For some participants access to the HED-SMART was difficult because of 
problems scheduling preferred language groups. The program was delivered in three 
languages (English, Mandarin, Malay) so as to better represent the national 
population, but this multi-language approach coupled with delivery in group format 
and restrained resources, led to attrition between recruitment and commencement. 
Finally, because of the multifaceted nature of the HED-SMART program, in regards 
to its delivery methods and content, it is not possible to identify what aspects of the 
intervention were responsible for the observed effects. It should be recognized that the 
support participants received from each other during the group sessions and increased 
attention from trial staff could have contributed to the observed improvements. Future 
work should consider including a matched attention control condition to determine 
these potential confounding effects. 
In conclusion, this trial indicates that a theory-based self-management 
intervention for patients with ESRD on hemodialysis is capable of initiating and 
maintaining improvements in clinical markers, self-management skills, self-efficacy 
and self-reported adherence up to 9 months post-intervention. Future research is 
needed to identify the intervention processes that led to these positive improvements, 
the subpopulations more likely to benefit, as well as the cost-effectiveness of the 
program. Work towards better implementation and refinement of HED-SMART to 
include ongoing support is critical to inform translation of this intervention into usual 
care. 
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Table 1. Participants’ Characteristics  
 
 
Total 
sample 
M±Sd /%(N) 
HED-
SMART 
M±Sd / %(N) 
Usual Care 
M±Sd /%(N) 
p 
Age (years) 53.5 (10.4) 53.1 (10.5) 53.9 (10.4) 0.5a 
Age at diagnosis (years) 43.4 (13.5) 42.9 (13.3) 43.7 (13.8) 0.7a 
Age left education (years) 16.7 (6.0) 17.1 (7.4) 16.4 (4.7) 0.3a 
Education level 
Illiterate/primary 
Secondary 
Tertiary 
 
71 (30.2) 
147 (62.6) 
17 (7.2) 
 
28 (27.7) 
69 (68.3) 
4 (4) 
 
43 (32.1) 
78 (58.2) 
13 (9.7) 
 
0.1b 
Gender, (female) 41.7% (98) 46.1% (47) 38.3% (51) 0.3b 
Ethnicity     0.9b 
Chinese 56.8% (133) 55.9% (57) 57.6% (76)  
Malay 34.2% (80) 35.3% (36) 33.3% (44)  
Indian 6.4% (15) 6.9% (7) 6.1% (8)  
Others 2.5% (6) 2% (2) 3.1% (4)  
Relationship status 
(married) 
66.5% (155)   67.3% (68) 65.9% (87) 
0.9 b 
 
Employment, (employed)  45.6% (93) 37.5% (33) 51.7% (60)  
Perceived ability to work 
(able to work) 
56.8% (129) 51.0% (52) 61.6% (77) 
 
Income1,2     
S$0- S$2,000 51.5% (119) 58.4% (59) 46.2% (60) 0.1c 
S$2,001 - S$4,000 21.2% (49) 15.8% (16) 25.4% (33)  
24 
S$4,001 - S$6,000 4.8% (11) 5.0% (5) 4.6% (6)  
> S$6,000 3.9% (9) 5.0% (5) 3.1% (4)  
Time on dialysis     
6-12 months 8.5%  (20) 8.8% (9) 8.3% (11) 0.8 
13-24 months 14.5% (3.4) 15.7% (16) 13.5% (18)  
> 24 months  77.0% (181) 75.5% (77) 78.2% (104)  
Time on dialysis (years)  5.68 (4.76) 5.83 (5.09) 5.81 (4.53) 0.9a 
Primary Cause of ESRD 
Glomerulonephritis  
Diabetic Nephropathy 
Polycystic Kidney 
Disease 
Hypertension 
 
28.9% (68) 
25.9% (61) 
 
8.1% (19) 
 
26.5% (27) 
27.5% (28) 
 
8.8% (9) 
 
30.8% (41) 
24.8% (33) 
 
7.5% (10) 
 
CCI 4.89 (2.23) 4.88 (2.19) 4.90 (2.27) 0.9a 
Kt/V 1.61 (0.20) 1.63 (0.18) 1.60 (0.22) 0.4a 
nPCR g/kg/day 1.01 (0.26) 1.01 (0.21) 0.99 (0.30) 0.6a 
Hemoglobin (g/dl) 11.54 (1.47) 11.55 (1.27) 11.54 (1.61) 0.9a 
Albumin (g/dl) 34.81 (2.99) 34.62 (3.03) 34.95 (2.97) 0.4a 
 Note: CCI = Charlson Comorbidity Index; nPCR = Normalized Protein Catabolic 
Rate 
 1 † ‡N = 189 as N = 14 participants ticked option ‘do not wish to answer’ for income 
and N = 32 indicated ‘do not know’ 
 2 Income  brackets are equivalent to US dollars as follows: S$2000 = US$1600; 
S$4000 = US$3200; S$6000 = US$4800. The median monthly household income of 
the Singapore population was S$3770 in 2014 (MOM).  
25 
aUse of independent-samples T-test. 
 bUse of χ2-test. 
 c Use of Fisher exact test as the number of expected count is <5. 
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Table 2. Primary outcomes: Clinical markers across assessment points for trial arm 
(ITT values) 
   HED-SMART Usual care   
  M±Sd %1 M±Sd %1 p2 (M) p3(%) 
IDWG T1 2.49±0.71 43.6% 2.46±0.69 44.5% 0.7 0.9 
(kg) T2 2.31±0.60 25.7% 2.50±0.74 44.5% 0.03 0.003 
 T3 2.32±0.54 30.7% 2.55±0.72 51.7% 0.006 0.002 
 T4 2.31±0.60 32.7% 2.45±0.71 43.8% 0.1 0.09 
IDWG 
(percentile) 
 
T1 
T2 
T3 
T4 
3.93±1.01 
3.67±0.85 
3.72±0.80 
3.68±0.86 
 
3.93±1.07 
4.00±1.19 
4.04±1.11 
3.90±1.11 
 
0.9 
0.02 
0.02 
0.1 
 
        
Phosphate T1 5.16±1.45 48.0% 5.15±1.27 44.4% 0.9 0.07 
(mg/dL) T2 5.05±1.44 51.0% 5.33±1.22 58.6% 0.1 0.9 
 T3 4.86±1.30 41.2% 5.30±1.18 51.1% 0.01 0.03 
 T4 5.03±1.16 43.0% 5.38±1.06 48.8% 0.02 0.9 
        
Potassium T1 5.00±0.64 51.0% 4.89±0.52 38.3% 0.1 0.6 
(mEq/L) T2 4.93±0.57 58.2% 4.91±0.60 37.6% 0.8 0.2 
 T3 4.72±0.55 32.4% 5.00±0.59 46.6% <.001 0.1 
 T4 4.86±0.60 40.2% 4.96±0.55 39.8% 0.2 0.4 
1 Percentages of participants with values off clinical targets 
2 Between group comparisons on mean clinical levels 
27 
3 Between group comparisons on proportions of clinical markers outside clinical 
targets  
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Table 3. Secondary outcomes: Self-reported adherence, Self-Efficacy and Health 
Education Impact Subscales  
   HED-SMART   Usual Care pa d 
  pb   pb    
RABQ Total  T1 a 92.2 ± 10.9 T1 a 90.2 ± 13.0 .229 .16 
T2 b 95.9 ± 11.8 T2 b 87.6 ± 14.8 .000 .60 
T3 b 94.7 ± 11.8 T3 c 90.0 ± 13.6 .007 .33 
T4 b 95.2 ± 11.4 T4 c 91.4 ± 12.0 .017 .29 
  pb   pb    
Fluid 
Restrictions 
T1 a 38.44 ± 5.42 T1 a,b 37.74 ± 6.55 .388 .12 
T2 b 40.14 ± 5.99 T2 a 36.76 ± 7.04 < .001 .51 
T3 b 39.61 ± 5.96 T3 b 37.86 ± 6.41 .036 .24 
T4 b 39.83 ± 6.10 T4 b 38.65 ± 6.20 .148 .17 
  pb   pb    
Potassium and 
Phosphate 
Intake 
T1 a 19.83 ± 2.95 T1 a 19.59 ± 2.77 .536 .08 
T2 b 20.49 ± 2.66 T2 b,c 19.09 ± 3.21 < .001 .46 
T3 b 20.66 ± 2.95 T3 a,c 19.29 ± 3.12 .001 .43 
T4 b 20.43 ± 2.97 T4 a,c 19.54 ± 3.00 .025 .29 
  pb   pb    
Sodium Intake T1 a 7.62 ± 1.82 T1 a 7.41 ± 1.84 .387 .12 
T2 b,c 8.03 ± 1.73 T2 a 7.29 ± 1.86 .002 .41 
T3 a,c 7.88 ± 1.78 T3 a 7.47 ± 1.68 .069 .24 
T4 b,c 8.13 ±1.63 T4 a 7.51 ± 1.65 .005 .38 
  pb   pb    
T1 a 19.12± 3.14 T1 a 18.75 ± 3.50 .398 .11 
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Adherence in 
Times of 
Difficulty 
T2 b,c 19.84 ± 3.27 T2 b,c 17.92 ± 3.71 < .001 .55 
T3 a,c 19.39 ± 3.29 T3 a,c 18.53 ± 3.76 .072 .21 
T4 a,c 19.61 ± 3.17 T4 a 18.78 ± 3.22 .050 .25 
  pb   pb    
Adherence to 
Prescribed 
Medications 
T1 a 3.81 ± .690 T1 a 3.69 ± .835 .243 .16 
T2 a,c 3.92 ± .742 T2 b,c 3.57 ± .842 .001 .44 
T3 b,c 3.96 ± .689 T3 a 3.75 ± .927 .049 .26 
T4 a,c 3.93 ± .783 T4 a,c 3.66 ± .852 .013 .33 
  pb   pb    
Self-
Monitoring 
and Insight 
T1 a 3.11 ± .380 T1 a 3.00 ± .375 .035 .28 
T2 a 3.15 ± .407 T2 a 3.01 ± .396 .006 .37 
T3 a 3.15 ± .410 T3 a 2.94 ± .376 < .001 .55 
T4 a 3.18 ± .386 T4 a 2.96 ± .330 < .001 .62 
  pb   pb    
Constructive 
Attitudes and 
Approaches 
T1 a 3.03 ± .485 T1 a 2.94 ± .495 .149 .19 
T2 a 3.05 ± .494 T2 a 2.94 ± .492 .075 .24 
T3 a 3.05 ± .550 T3 a 2.94 ± .473 .110 .21 
T4 a 3.00 ± .547 T4 a 2.91 ± .460 .136 .20 
  pb   pb    
Skill and 
Technique 
Acquisition 
T1 a 2.80 ± .375 T1 a 2.78 ± .418 .737 .04 
T2 b 2.93 ± .462 T2 a 2.75 ± .431 .004 .39 
T3 b 2.93 ± .452 T3 a 2.74 ± .484 .002 .41 
T4 b 2.90 ± .472 T4 a 2.76 ± .432 .025 .30 
  pb   pb    
T1 a 2.95 ± .439 T1 a 2.97 ± .387 .752 -.04 
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Health Services 
Navigation 
T2 b 3.08 ± .473 T2 a 2.95 ± .461 .030 .29 
T3 b 3.06 ± .508 T3 a 2.90 ± .440 .011 .34 
T4 b 3.11 ± .533 T4 a 2.91 ± .452 .002 .41 
  pb   pb    
Disease-
Related Self-
Efficacy 
T1 a 6.66 ± 1.76 T1 a 6.03 ± 1.63 .006 .37 
T2 b,c 7.02 ± 1.70 T2 a 5.99 ± 1.77 < .001 .59 
T3 a,c 6.82 ± 1.76 T3 a 6.02 ± 1.68 .001 .46 
T4 a,c 6.81 ± 1.67 T4 b 6.33 ± 1.74 .035 .28 
  pb   pb    
Treatment-
Related Self-
Efficacy 
T1 a 7.30 ± 1.66 T1 a 6.91 ± 1.54 .067 .25 
T2 b,c 7.71 ± 1.44  T2 b 6.57 ± 1.76 < .001 .70 
T3 b,c 7.57 ± 1.43 T3 b 6.60 ±1.71 < .001 .61 
T4 a,c 7.48 ± 1.48  T4 a 6.93 ± 1.55 .007 .36 
         
Note. Data are expressed as mean ± Sd; RABQ = Renal Adherence Behavior 
Questionnaire. 
a Between group comparisons on secondary outcomes. 
b Within group comparisons on secondary outcomes. For each outcome, and within 
each group, means which do not share the same superscripted letter are different from 
each other at the .05 level of significance.  
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Figure. 1 Consolidated Standards of Reporting Trials (CONSORT) diagram for 
patient flow from initial contact through completion of the trial.  
